Top News
Depressive Symptoms May Be Associated With Survival in Patients With Hematologic Malignancies
Diagnostic Delay in Diffuse Large B-Cell Lymphoma Linked to Poorer Outcomes for Patients With Worse Disease
Novel Test Accurately Identifies Precancerous Pancreatic Cysts
Prostate Cancer ADT Raises Dementia Risk, Study Finds
Use of Pathogenic BRCA1/2 Alterations as Pan-Cancer Biomarkers for Therapy Selection May Not be Appropriate
Potential Early Drivers of Disease in Treatment-Naive CLL Identified
Proposed CMS Rule Change Would Restrict Access to Anticancer Medications
Surveillance Imaging Not Linked to Better Outcomes in Follicular Lymphoma, Further Evidence Shows
Frailty Predicts Higher In-Hospital Mortality After Radical Cystectomy
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Study Shows Benefit of Multiple Assessments of MRD in Multiple Myeloma
A study affirmed the benefits of a multimodal approach in the assessment of minimal residual disease in multiple myeloma. -
Waiting for CAR-T
Choosing the best bridging therapy for a patient, prior to administration of CAR-T, is dependent on the patient’s disease characteristics. -
Study Comparing Targeted With Nontargeted Therapies in Patients With Metastatic RCC May Not Account for Recent Advances in Immunotherapy
There has been a sea change in outcomes from patients treated before 2007 for renal cell carcinoma, according to an expert. -
Research Examines Breast Cancer Susceptibility Genes in Hispanic Women and Other Diverse Populations
The presence of CHEK2 or PALB2 variants in Hispanic women is enough to warrant the addition of an annual breast MRI, said study authors. -
Cancer Drug Development: How Therapies Move Through the Pipeline
This fact sheet explains the processes involved in drug development and FDA drug approval. -
Death Rates in Melanoma Fell Markedly Following the Proliferation of New Types of Therapies
Patients are now able to get immunotherapies and targeted therapies at their local clinics, rather than having to travel to academic medical centers.
More Features
RCC in Advanced CKD: A Transplant Dilemma
Non-dialysis patients with advanced CKD diagnosed with renal malignancies grapple with the dual threat of renal failure and cancer progression.
Are CTCs A Reliable Metric for Patient Stratification in Cancer?
It is still unknown whether liquid biopsies are a reliable mechanism for determining disease prognosis outside of prostate cancer.
CAR-T Therapy Injected Directly Into Chest Cavity Shows Early Promise in Pleural Cancers
Early results from a phase 1 clinical trial of CAR T cells administered directly into the chest cavity for the treatment of pleural cancers has shown low toxicity and high efficacy.
Fragmentation Pattern of Cell-Free DNA Can Reveal Cancer, Even at Early Stages
Machine learning algorithm detected 7 types of cancer in liquid biopsy and identified tissue of disease origin.
Upfront Next-Generation Sequencing for Lung Cancer: Can It Save Time and Money?
Upfront NGS saves time and money compared with the sequential use of individual gene tests for patients with metastatic lung cancer, according to study authors.
